# Innsuites Hospitality Trust: overview IHT · NYSE · CIK 82473 · [Real estate](/sectors/real-estate.md) · fiscal year ends Jan 31 Pages: [Overview](/companies/iht.md) · [Financials](/companies/iht/financials.md) · [Filings](/companies/iht/filings.md) · [Insiders](/companies/iht/insiders.md) Latest reported revenue: [$1.8m](/filings/0001493152-26-042806.md) for Q2 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 16, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-042806). ## Last eight quarters | Line item | Unit | period not labelled (2024-10-31) | Q4 FY2025 (2025-01-31) | period not labelled (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,825](/filings/0001493152-25-027802.md) | [1,634 d](/filings/0001493152-26-029173.md) | [2,206](/filings/0001493152-26-029438.md) | [1,799](/filings/0001493152-26-042806.md) | [1,805](/filings/0001493152-25-027802.md) | [1,758 d](/filings/0001493152-26-029173.md) | [2,194](/filings/0001493152-26-029438.md) | [1,837](/filings/0001493152-26-042806.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(7.1%)](/filings/0001493152-25-027802.md) | [(29.9%) d](/filings/0001493152-26-029173.md) | [10.1%](/filings/0001493152-26-029438.md) | [(13.3%)](/filings/0001493152-26-042806.md) | [(10.0%)](/filings/0001493152-25-027802.md) | [(20.6%) d](/filings/0001493152-26-029173.md) | [7.9%](/filings/0001493152-26-029438.md) | [(9.8%)](/filings/0001493152-26-042806.md) | | Net margin | % | [(15.1%)](/filings/0001493152-25-027802.md) | [(35.5%) d](/filings/0001493152-26-029173.md) | [(5.5%)](/filings/0001493152-26-029438.md) | [(21.7%)](/filings/0001493152-26-042806.md) | [(19.8%)](/filings/0001493152-25-027802.md) | [(31.7%) d](/filings/0001493152-26-029173.md) | [(0.8%)](/filings/0001493152-26-029438.md) | [(12.5%)](/filings/0001493152-26-042806.md) | | Diluted EPS | $ per share | [(0.03)](/filings/0001493152-25-027802.md) | not reported | [(0.01)](/filings/0001493152-26-029438.md) | [(0.04)](/filings/0001493152-26-042806.md) | [(0.04)](/filings/0001493152-25-027802.md) | not reported | [0.00](/filings/0001493152-26-029438.md) | [(0.02)](/filings/0001493152-26-042806.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-01-31) | FY2023 (2023-01-31) | FY2024 (2024-01-31) | FY2025 (2025-01-31) | FY2026 (2026-01-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [6,410](/filings/0001493152-23-015101.md) | [7,146](/filings/0001493152-24-013409.md) | [7,484](/filings/0001641172-25-007998.md) | [7,594](/filings/0001493152-26-029173.md) | [7,567](/filings/0001493152-26-029173.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(4.7%)](/filings/0001493152-23-015101.md) | [(4.2%)](/filings/0001493152-24-013409.md) | [(9.6%)](/filings/0001641172-25-007998.md) | [(9.8%)](/filings/0001493152-26-029173.md) | [(7.4%)](/filings/0001493152-26-029173.md) | | Net margin | % | [4.0%](/filings/0001493152-23-044024.md) | [7.3%](/filings/0001493152-24-013409.md) | [2.7%](/filings/0001641172-25-007998.md) | [(18.3%)](/filings/0001493152-26-029173.md) | [(18.8%)](/filings/0001493152-26-029173.md) | | Diluted EPS | $ per share | not reported | [0.06](/filings/0001493152-24-013409.md) | [0.02](/filings/0001641172-25-007998.md) | [(0.16)](/filings/0001493152-26-029173.md) | [(0.16)](/filings/0001493152-26-029173.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/iht/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $138.0k | 81,203 | | Reduced −5,700 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $82.1k | 48,276 | | New +48,276 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $60.0k | 35,317 | | Unchanged | | [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $45.6k | 26,819 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $32.8k | 19,275 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $27.4k | 16,092 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $27.2k | 15,983 | | Reduced −2,570 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $19.7k | 11,581 | | New +11,581 | | [Carnegie Mellon University](/funds/1039067.md) | 2026-06-30 | $17.0k | 10,000 | | Unchanged | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $8.8k | 5,192 | | New +5,192 | ## Recent filings [All 384 filings](/companies/iht/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-16 | 01:27 ET | [10-Q](/filings/0001493152-26-042806.md) | Quarterly report, period 2026-07-31 | 0001493152-26-042806 | | 2026-09-15 | 02:00 ET | [8-K](/filings/0001493152-26-042648.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-042648 | | 2026-08-20 | 10:27 ET | [8-K](/filings/0001493152-26-039352.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-039352 | | 2026-08-14 | 21:27 ET | [8-K](/filings/0001493152-26-038529.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038529 | | 2026-07-10 | 01:55 ET | [8-K](/filings/0001493152-26-032754.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-032754 | | 2026-07-09 | 21:27 ET | [DEF 14A](/filings/0001493152-26-032726.md) | Proxy statement, period 2026-07-09 | 0001493152-26-032726 | | 2026-07-01 | 01:59 ET | [8-K](/filings/0001493152-26-031405.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-031405 | | 2026-06-22 | 01:57 ET | [10-Q](/filings/0001493152-26-029438.md) | Quarterly report, period 2026-04-30 | 0001493152-26-029438 | | 2026-06-18 | 10:26 ET | [10-K/A](/filings/0001493152-26-029173.md) | Annual report, amended, period 2026-01-31 | 0001493152-26-029173 | | 2026-05-19 | 12:25 ET | [10-K](/filings/0001493152-26-024361.md) | Annual report, period 2026-01-31 | 0001493152-26-024361 | ## Latest annual report [Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001493152-26-024361.md), filed May 19, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 82473 - Tickers: IHT - Exchange: NYSE - SIC code: 6798 Real Estate Investment Trusts - State of incorporation: OH - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.